Psyence Biomedical Ltd. (PBM) Long-Term Investments (2023 - 2026)

Psyence Biomedical's Long-Term Investments history runs 3 years deep, the most recent figure standing at $8.1 million for Q1 2026.

• In Q1 2026, Long-Term Investments rose 982.0% year-over-year to $8.1 million; the TTM figure through Mar 2026 stood at $8.1 million (up 982.0% YoY), while the FY2026 annual figure was $8.1 million, up 982.0% from the prior year.
• Long-Term Investments for Q1 2026 stood at $8.1 million, up from $5.2 million in the prior quarter.
• The five-year high for Long-Term Investments was $12518.2 billion in Q3 2023, with the low at $745000.0 in Q1 2025.
• The 3-year median for Long-Term Investments is $6.6 million (2025), against an average of $3129.6 billion.
• Peak annual rise in Long-Term Investments reached 982.0% in 2026, while the deepest fall reached 982.0% in 2026.
• Psyence Biomedical's Long-Term Investments stood at $12518.2 billion in 2023, then sank by 100.0% to $5.2 million in 2025, then soared by 55.86% to $8.1 million in 2026.
• Business Quant data shows PBM's Long-Term Investments at $8.1 million in Q1 2026, $5.2 million in Q3 2025, and $745000.0 in Q1 2025.